We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Notice for belzutifan (Merck Sharp & Dohme (Australia) Pty Ltd)
Active ingredients
belzutifan
Date of review outcome
Lapse date
Type
Provisional determination
Dosage form(s)
Immediate-release tablet
Therapeutic area
Oncology